11C-NS14492 as a novel PET radioligand for imaging cerebral alpha7 nicotinic acetylcholine receptors: in vivo evaluation and drug occupancy measurements

Research output: Contribution to journalJournal articleResearchpeer-review

  • Anders Ettrup
  • Jens D Mikkelsen
  • Szabolcs Lehel
  • Jacob Madsen
  • Elsebet Ø Nielsen
  • Mikael Palner
  • Daniel B Timmermann
  • Dan Peters
  • Knudsen, Gitte Moos
Small-molecule a(7) nicotinic acetylcholine receptor (a(7)nAChR) agonists are currently validated for use as treatment for cognitive disturbances in schizophrenia and in Alzheimer disease. A suitable radiolabeled a(7)nAChR PET tracer would be important for in vivo quantification of a(7)nAChR binding in humans and to measure a(7)nAChR occupancy of a(7)nAChR drug candidates. Here, we present the radiosynthesis and in vivo evaluation of (11)C-NS14492 as a selective a(7)nAChR PET radioligand.
Original languageEnglish
JournalJournal of Nuclear Medicine
Volume52
Issue number9
Pages (from-to)1449-56
Number of pages8
ISSN0161-5505
DOIs
Publication statusPublished - 2011

ID: 40216005